Timothy Edwin Kelly - 12 May 2023 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Financial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
12 May 2023
Net transactions value
+$10,328
Form type
4
Filing time
18 May 2023, 21:49:22 UTC
Previous filing
06 Apr 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $10,328 +11,683 +25% $0.8840 58,099 12 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).